Novo Nordisk
NVO
#98
Rank
โ‚น18.978 T
Marketcap
โ‚น4,295
Share price
-3.09%
Change (1 day)
-10.31%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.254 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.37 Billion. In 2025 the company made an earning of โ‚น1.993 Trillion, an increase over its 2024 earnings that were of โ‚น1.875 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.254 T13.11%
2025 โ‚น1.993 T6.28%
2024 โ‚น1.875 T28.01%
2023 โ‚น1.465 T57.81%
2022 โ‚น928.47 B5.24%
2021 โ‚น882.27 B12.38%
2020 โ‚น785.06 B13.11%
2019 โ‚น694.08 B-3.45%
2018 โ‚น718.88 B1.88%
2017 โ‚น705.59 B4.3%
2016 โ‚น676.48 B10.32%
2015 โ‚น613.18 B7.47%
2014 โ‚น570.58 B3.4%
2013 โ‚น551.81 B19.09%
2012 โ‚น463.37 B15.58%
2011 โ‚น400.92 B16.58%
2010 โ‚น343.91 B25.66%
2009 โ‚น273.69 B10.68%
2008 โ‚น247.28 B55.82%
2007 โ‚น158.70 B7.02%
2006 โ‚น148.29 B19.05%
2005 โ‚น124.56 B10.55%
2004 โ‚น112.67 B
2002 โ‚น75.90 B-14.39%
2001 โ‚น88.66 B-52.82%
2000 โ‚น187.91 B250%
1999 โ‚น53.68 B31.21%
1998 โ‚น40.91 B34.31%
1997 โ‚น30.46 B11.46%
1996 โ‚น27.33 B9.03%
1995 โ‚น25.06 B-3.15%
1994 โ‚น25.88 B-0.67%
1993 โ‚น26.05 B45.38%
1992 โ‚น17.92 B-13.81%
1991 โ‚น20.79 B37.12%
1990 โ‚น15.16 B-0.79%
1989 โ‚น15.28 B26.2%
1988 โ‚น12.11 B24.97%
1987 โ‚น9.69 B-0.9%
1986 โ‚น9.78 B-7.78%
1985 โ‚น10.60 B24.87%
1984 โ‚น8.49 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.007 T-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.959 T 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น728.32 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น912.67 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA